Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-3-16
pubmed:abstractText
The aim of this study was to relate the CpG island methylator phenotype (CIMP; characterized by extensive promoter hypermethylation) to cancer-specific survival in colorectal cancer, taking into consideration relevant clinicopathologic factors, such as microsatellite instability (MSI) screening status and the BRAF V600E mutation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1845-55
pubmed:meshHeading
pubmed-meshheading:20197478-Adult, pubmed-meshheading:20197478-Aged, pubmed-meshheading:20197478-Colorectal Neoplasms, pubmed-meshheading:20197478-CpG Islands, pubmed-meshheading:20197478-DNA Methylation, pubmed-meshheading:20197478-Female, pubmed-meshheading:20197478-Gene Expression Regulation, Neoplastic, pubmed-meshheading:20197478-Humans, pubmed-meshheading:20197478-Immunoenzyme Techniques, pubmed-meshheading:20197478-Male, pubmed-meshheading:20197478-Microsatellite Instability, pubmed-meshheading:20197478-Middle Aged, pubmed-meshheading:20197478-Mutation, pubmed-meshheading:20197478-Phenotype, pubmed-meshheading:20197478-Prognosis, pubmed-meshheading:20197478-Promoter Regions, Genetic, pubmed-meshheading:20197478-Proto-Oncogene Proteins B-raf, pubmed-meshheading:20197478-Survival Rate
pubmed:year
2010
pubmed:articleTitle
The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status.
pubmed:affiliation
Department of Medical Biosciences, Pathology, and Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden. anna.dahlin@medbio.umu.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't